DNS - Enoxaparin 15 000 IU/ml
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 12/2021/ÚVN | 12. 01. 2021 | sanofi-aventis, s.r.o. | 41 948,39 | 38 134,90 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| Poj.smlouva_konverze_anonymized.pdf | Smlouva | 27. 01. 2021 11:25 | Dokument není zavirovaný | ||
| Smlouva Enoxaparin 15000 ÚVN anonymized.pdf | Smlouva | 27. 01. 2021 11:25 | Dokument není zavirovaný | ||
| Smlouva Enoxaparin 15000 VNOL anonymized.pdf | Smlouva | 27. 01. 2021 11:25 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| sanofi-aventis, s.r.o. | Praha | CZK |
Price Actually Paid in Each Year of Performance
| 12/2021/ÚVN | 2023 | 0,00 | 0,00 |
| 12/2021/ÚVN | 2022 | 0,00 | 0,00 |
| 12/2021/ÚVN | 2021 | 18 016,13 | 16 378,30 |